Dynamic contrast-enhanced computed tomography for the quantification of tumor response to vasoactive agents in a rat tumor model: Preliminary results

Contrast Media and Molecular Imaging

Volumn 6, Issue 1, 2011, Pages 28-34

  Pollard, Rachel E ^a   Larson, Richard F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dynamic contrast CT; Tumor blood flow; Tumor oxygenation

Indexed keywords

HYDRALAZINE; IODINATED CONTRAST MEDIUM; IOPAMIDOL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; FIBER OPTIC BIOSENSOR; MALE; NONHUMAN; OXYGEN SENSING; OXYGEN TENSION; PILOT STUDY; PRIORITY JOURNAL; RAT; THIGH; TISSUE OXYGENATION; TISSUE PERFUSION; TUMOR BLOOD FLOW; TUMOR MODEL;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; HYDRALAZINE; MALE; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN CONSUMPTION; PILOT PROJECTS; PROGNOSIS; RATS; RATS, INBRED F344; REGIONAL BLOOD FLOW; TOMOGRAPHY, X-RAY COMPUTED; VASODILATOR AGENTS;

EID: 79951994115     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.399     Document Type: Article

References (28)

1. Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999; 86(8): 1528-1536.
2. Hockel M, Schlenger K, Hockel S, Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 1999; 59(18): 4525-4528.
3. Stadler P, Becker A, Feldmann HJ, et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 44(4): 749-754.
4. Sundfor K, Lyng H, Rofstad EK. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 1998; 78(6): 822-827.
5. Vaupel P, Kelleher DK, Hockel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001; 28 (2 suppl 8): 29-35.
6. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86(3): 353-364.
7. Broll R, Erdmann H, Duchrow M, et al. Vascular endothelial growth factor (VEGF) - a valuable serum tumour marker in patients with colorectal cancer? Eur J Surg Oncol 2001; 27(1): 37-42.
8. Mineta H, Miura K, Ogino T, et al. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 2000; 83(6): 775-781.
9. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143(2): 401-409.
10. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999; 20(1): 63-73.
11. Nabavi DG, Cenic A, Henderson S, Gelb AW, Lee TY. Perfusion mapping using computed tomography allows accurate prediction of cerebral infarction in experimental brain ischemia. Stroke 2001; 32(1): 175-183.
12. Peterson KL, MacLeod AG, Wisner ER, Larson RF, Pollard RE. Quantitative assessment of blood volume, blood flow, and permeability of the brain of clinically normal dogs by use of dynamic contrast-enhanced computed tomography. Am J Vet Res 2008; 69(1): 45-50.
13. Haider MA, Milosevic M, Fyles A, et al. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys 2005; 62(4): 1100-1107.
14. Pollard RE, Broumas AR, Wisner ER, Vekich SV, Ferrara KW. Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats. Ultrasound Med Biol 2007; 33(2): 235-245.
15. Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 2005; 234(3): 785-792.
16. Hindmarsh T. Elimination of water-soluble contrast media from the subarachnoid space. Investigation with computer tomography. Acta Radiol Suppl 1975; 346: 45-49.
17. Jarm T, Sersa G, Miklavcic D. Oxygenation and blood flow in tumors treated with hydralazine: evaluation with a novel luminescence-based fiber-optic sensor. Technol Health Care 2002; 10(5): 363-380.
18. Trotter MJ, Acker BD, Chaplin DJ. Histological evidence for nonperfused vasculature in a murine tumor following hydralazine administration. Int J Radiat Oncol Biol Phys 1989; 17(4): 785-789.
19. Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001; 7(9): 987-989.
20. Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 2004; 64(11): 3731-3736.
21. Hansen-Algenstaedt N, Stoll BR, Padera TP, et al. Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy. Cancer Res 2000; 60(16): 4556-4560.
22. Lee CG, Heijn M, di Tomaso E, et al. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 2000; 60(19): 5565-5570.
23. Milosevic MF, Fyles AW, Hill RP. The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis. Int J Radiat Oncol Biol Phys 1999; 43(5): 1111-1123.
24. Boucher Y, Lee I, Jain RK. Lack of general correlation between interstitial fluid pressure and oxygen partial pressure in solid tumors. Microvasc Res 1995; 50(2): 175-182.
25. Elie N, Kaliski A, Peronneau P, Opolon P, Roche A, Lassau N. Methodology for quantifying interactions between perfusion evaluated by DCE-US and hypoxia throughout tumor growth. Ultrasound Med Biol 2007; 33(4): 549-560.
26. Optronix O. OxyLite User Manual Version 1.12. Oxford Optronix Ltd, Oxford, 1998.
27. Optronix O. OxyFlo User Manual Version 1.03. Oxford Optronix Ltd, Oxford, 2000.
28. Su MY, Wang Z, Roth GM, Lao X, Samoszuk MK, Nalcioglu O. Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn Reson Med 1996; 36(6): 868-877.